Montaz 125mg Injection
By Montaz
Rx
1 Injection in a Vial

Composition
Ceftriaxone(125mg) + Tazobactum(15.6mg)

Manufacturer - Aristo Pharmaceuticals Pvt Ltd
Mercantile Chamber, 3rd Floor, 12, J.N. Heredia Marg, Ballard Estate, Mumbai – 400 001, India.

Expires on or after
August, 2025

liver
When using Montaz 125mg Injection, it is important to be cautious if you have severe liver disease. Patients with severe liver issues may require a dose adjustment when taking Montaz 125mg Injection. It is advisable to consult your doctor for proper guidance in such cases. However, for patients with mild to moderate liver disease, dose adjustment of Montaz 125mg Injection is generally not recommended. Always seek medical advice and follow your doctor's recommendations regarding the use of Montaz 125mg Injection to ensure your liver health is properly managed.

kidney
Limited information exists on using Montaz 125mg Injection in kidney disease patients. Consult your doctor.

alcohol
It is safe to consume alcohol with Montaz 125mg Injection as it does not have any negative effects.

driving
When using Montaz 125mg Injection, be careful when driving as it may lower alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Montaz 125mg Injection is generally safe during pregnancy as animal studies show minimal adverse effects on the baby. Human studies are limited.

breastfeeding
Montaz 125mg Injection should be used cautiously while breastfeeding. It is advisable to pause breastfeeding until the mother's treatment is finished and the drug is cleared from her body.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹36
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024